Literature DB >> 18368514

Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure.

Lili Li1, Shuo Zhang, Yao Zhang, Bo Yu, Yan Xu, Zhenzhong Guan.   

Abstract

OBJECTIVE: We aimed to investigate the mechanism mediating the antifibrotic effects of mesenchymal stem cells (MSCs) via in vitro and in vivo study.
METHODS: In vitro, cardiac fibroblasts (CFs) from passage 2 were cultured and incubated with DMEM/F12 supplemented with 10% fetal bovine serum (DM-10), DM-10 containing angiotensin II (Ang II, 1 x 10(-6) M) or a combination of MSC-conditioned medium (MSC-CM) and Ang II (1 x 10(-6) M) for 48 h. CFs proliferation and gene expression of collagen I and III were analyzed by MTT and reverse transcription-polymerase chain reaction (RT-PCR). In vivo, global heart failure was induced in Wistar rats by isoproterenol (ISO) injection. Four weeks later, MSCs or culture medium were transplanted by intramyocardial injection. Four weeks after transplantation, heart function was assessed, and histological analysis conducted. In addition, the expression of adrenomedullin (ADM), an antifibrotic factor, in MSCs and myocardium were also examined.
RESULTS: In vitro, MSCs expressed ADM. MSC-CM obviously inhibited CFs proliferation and expression of collagen I and III mRNA. In vivo, compared with medium transplantation, MSC transplantation significantly improved heart function, decreased collagen volume fraction and increased expression of ADM in myocardium.
CONCLUSIONS: MSC transplantation can inhibit function of CFs by secreting antifibrotic factors such as ADM, resulting in decrease of myocardial fibrosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18368514     DOI: 10.1007/s11033-008-9235-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  20 in total

Review 1.  Mesenchymal stem cells: clinical applications and biological characterization.

Authors:  Frank P Barry; J Mary Murphy
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

2.  Cell transplantation preserves matrix homeostasis: a novel paracrine mechanism.

Authors:  Paul W M Fedak; Paul E Szmitko; Richard D Weisel; Svetlana M Altamentova; Nafiseh Nili; Nobuhisa Ohno; Subodh Verma; Shafie Fazel; Bradley H Strauss; Ren-Ke Li
Journal:  J Thorac Cardiovasc Surg       Date:  2005-10-13       Impact factor: 5.209

3.  Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure.

Authors:  Patrick I McConnell; Carlos L del Rio; Douglas B Jacoby; Martina Pavlicova; Pawel Kwiatkowski; Agatha Zawadzka; Jonathan H Dinsmore; Louis Astra; Sheik Wisel; Robert E Michler
Journal:  J Thorac Cardiovasc Surg       Date:  2005-09-02       Impact factor: 5.209

4.  Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling.

Authors:  Ryota Uemura; Meifeng Xu; Nauman Ahmad; Muhammad Ashraf
Journal:  Circ Res       Date:  2006-05-11       Impact factor: 17.367

5.  Angiotensin II-stimulated collagen production in cardiac fibroblasts is mediated by reactive oxygen species.

Authors:  Paul Lijnen; Italia Papparella; Victor Petrov; Andrea Semplicini; Robert Fagard
Journal:  J Hypertens       Date:  2006-04       Impact factor: 4.844

Review 6.  Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms.

Authors:  K T Weber; Y Sun; S C Tyagi; J P Cleutjens
Journal:  J Mol Cell Cardiol       Date:  1994-03       Impact factor: 5.000

Review 7.  Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways.

Authors:  Bodh I Jugdutt
Journal:  Curr Drug Targets Cardiovasc Haematol Disord       Date:  2003-03

8.  Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo.

Authors:  Chrishan S Samuel; Elaine N Unemori; Ishanee Mookerjee; Ross A D Bathgate; Sharon L Layfield; John Mak; Geoffrey W Tregear; Xiao-Jun Du
Journal:  Endocrinology       Date:  2004-05-20       Impact factor: 4.736

Review 9.  Adrenomedullin--what do we know 10 years since its discovery?

Authors:  Jerzy Bełtowski; Anna Jamroz
Journal:  Pol J Pharmacol       Date:  2004 Jan-Feb

10.  Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro.

Authors:  Francesco Alviano; Valentina Fossati; Cosetta Marchionni; Mario Arpinati; Laura Bonsi; Michele Franchina; Giacomo Lanzoni; Silvia Cantoni; Claudia Cavallini; Francesca Bianchi; Pier Luigi Tazzari; Gianandrea Pasquinelli; Laura Foroni; Carlo Ventura; Alberto Grossi; Gian Paolo Bagnara
Journal:  BMC Dev Biol       Date:  2007-02-21       Impact factor: 1.978

View more
  53 in total

Review 1.  Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step.

Authors:  James D Richardson; Adam J Nelson; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley; Peter J Psaltis
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 2.  Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions.

Authors:  Santosh K Sanganalmath; Roberto Bolli
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

3.  VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function.

Authors:  Troy A Markel; Yue Wang; Jeremy L Herrmann; Paul R Crisostomo; Meijing Wang; Nathan M Novotny; Christine M Herring; Jiangning Tan; Tim Lahm; Daniel R Meldrum
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-10       Impact factor: 4.733

4.  Functions of Mesenchymal Stem Cells in Cardiac Repair.

Authors:  Selçuk Öztürk; Ayşe Eser Elçin; Yaşar Murat Elçin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Therapeutic potential effect of bone marrow-derived mesenchymal stem cells on chronic liver disease in murine Schistosomiasis Mansoni.

Authors:  Mohamed H Hegab; Somia H Abd-Allah; Maha S Badawey; Ayman A Saleh; Ashraf S Metwally; Ghada M Fathy; Soad M Nada; Sara A Abdel-Rahman; Amira A Saleh; Amal Fawzy; Mohammed Abu El-Magd
Journal:  J Parasit Dis       Date:  2018-04-23

6.  SDF-1α inhibits hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells through PI3K/Akt and ERK1/2 signaling pathways.

Authors:  Qi Yin; Peifeng Jin; Xuebin Liu; Hua Wei; Xiaoming Lin; Chuang Chi; Yu Liu; Chengchao Sun; Yingjie Wei
Journal:  Mol Biol Rep       Date:  2010-04-10       Impact factor: 2.316

7.  Inhibition of penile tunica albuginea myofibroblasts activity by adipose-derived stem cells.

Authors:  Hesong Jiang; Qingqiang Gao; Xiaoyan Che; Leilei Zhu; Zheng Zhang; Yun Chen; Yutian Dai
Journal:  Exp Ther Med       Date:  2017-09-21       Impact factor: 2.447

8.  Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue.

Authors:  Sarah Tzu-Feng Hsiao; Azar Asgari; Zerina Lokmic; Rodney Sinclair; Gregory James Dusting; Shiang Yong Lim; Rodney James Dilley
Journal:  Stem Cells Dev       Date:  2012-02-03       Impact factor: 3.272

Review 9.  Stem cell therapy for chronic myocardial infarction.

Authors:  Manuel Mazo; Beatriz Pelacho; Felipe Prósper
Journal:  J Cardiovasc Transl Res       Date:  2010-01-21       Impact factor: 4.132

10.  Hypoxic conditioning enhances the angiogenic paracrine activity of human adipose-derived stem cells.

Authors:  Sarah T Hsiao; Zerina Lokmic; Hitesh Peshavariya; Keren M Abberton; Gregory J Dusting; Shiang Y Lim; Rodney J Dilley
Journal:  Stem Cells Dev       Date:  2013-03-15       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.